Webcast ImageWebcast
AnaptysBio Inc at Jefferies 2017 London Healthcare Conference (Replay)
11/16/17 at 4:00 p.m. GMT
AnaptysBio Inc at Jefferies 2017 London Healthcare Conference
Thursday, November 16, 2017 4:00 p.m. GMT  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
AnaptysBio Inc at Evercore ISI BioPharma Catalyst/Deep Dive Conference (fireside chat)  (Live)
11/29/17 at 4:35 p.m. ET
AnaptysBio Inc at Evercore ISI BioPharma Catalyst/Deep Dive Conference (fireside chat)
Wednesday, November 29, 2017 4:35 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013
 
Nov 07, 2017AnaptysBio Announces Third Quarter 2017 Financial Results and Provides Pipeline UpdatesPrinter Friendly Version
Nov 06, 2017AnaptysBio Reports Positive ANB019 Top-line Phase 1 Clinical Trial ResultsPrinter Friendly Version
Oct 31, 2017AnaptysBio to Participate in Upcoming Investor ConferencesPrinter Friendly Version
Oct 12, 2017AnaptysBio Announces Pricing of Public OfferingPrinter Friendly Version
Oct 10, 2017AnaptysBio Files Registration Statement for Proposed Public OfferingPrinter Friendly Version
Oct 10, 2017AnaptysBio Reports Positive Topline Proof-of-Concept Data from Phase 2a Clinical Trial of ANB020 in Atopic DermatitisPrinter Friendly Version
Aug 24, 2017AnaptysBio Announces Appointment of J. Anthony Ware, M.D. to Board of DirectorsPrinter Friendly Version
Aug 10, 2017AnaptysBio Announces Second Quarter 2017 Financial Results and Provides Pipeline UpdatesPrinter Friendly Version
Aug 08, 2017AnaptysBio to Present at Wedbush PacGrow Healthcare ConferencePrinter Friendly Version
Jun 01, 2017AnaptysBio to Participate in Upcoming Investor ConferencesPrinter Friendly Version
May 11, 2017AnaptysBio Announces First Quarter 2017 Financial Results and Provides Pipeline UpdatePrinter Friendly Version
Apr 06, 2017AnaptysBio Announces First-In-Human Dosing of ANB019Printer Friendly Version
Mar 08, 2017AnaptysBio Announces 2016 Operating Results and Pipeline ProgressPrinter Friendly Version
Mar 04, 2017AnaptysBio Announces Data from Scientific Collaboration with the Benaroya Research Institute Presented at the AAAAI 2017 Annual MeetingPrinter Friendly Version
Feb 13, 2017AnaptysBio to Present Data from ANB020 Program at Two Upcoming Medical MeetingsPrinter Friendly Version
Jan 31, 2017AnaptysBio Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesPrinter Friendly Version
Jan 25, 2017AnaptysBio Announces Pricing of Initial Public OfferingPrinter Friendly Version
Jan 11, 2017AnaptysBio Announces the Appointment of Dominic Piscitelli as Chief Financial OfficerPrinter Friendly Version
  |   |   |   |   |